The model integrates tumor angiogenesis, an adaptive immune response and immunosuppression. Tumor size at diagnosis can be used as a marker to select the most feasible type of treatment.
Book Title: A Cancer Treatment Based on Synergy Between Anti-angiogenic and Immune Cell Therapies
Author:
Published on 2016 by
ISBN: /
Total Page:
Book Category:
Book is About: Cancer Treatment
Get A Cancer Treatment Based on Synergy Between Anti-angiogenic and Immune Cell Therapies eBook
Abstract: A mathematical model integrating tumor angiogenesis and tumor-targeted cytotoxicity by immune cells was developed to identify the therapeutic window of two distinct modes to treat cancer: (1) an anti-angiogenesis treatment based on the monoclonal antibody bevacizumab that targets tumor vasculature, and (2) immunotherapy involving the injection of unlicensed dendritic cells to boost the anti-tumor adaptive response. The angiogenic cytokine Vascular Endothelial Growth Factor (VEGF) contributes to the immunosuppressive tumor microenvironment, which is responsible for the short-lived therapeutic effect of cancer-targeted immunotherapy. The effect of immunosuppression on the width of the therapeutic window of each treatment was quantified. Experimental evidence has shown that neutralizing immunosuppressive cytokines results in an enhanced immune response against infections and chronic diseases. The model was used to determine treatment protocols involving the combination of anti-VEGF and unlicensed dendritic cell injections that enhance tumor regression. The model simulations predicted that the most effective method to treat tumors involves administering a series of biweekly anti-VEGF injections to disrupt angiogenic processes and limit tumor growth. The simulations also verified the hypothesis that reducing the concentration of the immunosuppressive factor VEGF prior to an injection of unlicensed dendritic cells enhances the cytotoxicity of CD8+ T cells and results in complete tumor elimination. Feasible treatment protocols for tumors that are diagnosed late and have grown to a relatively large size were identified. Highlights: Distinct therapeutic windows are predicted to exist for an anti-VEGF treatment and for DC immunotherapy. Conditions leading to synergy between an anti-VEGF treatment and DC immunotherapy were identified. The model integrates tumor angiogenesis, an adaptive immune response and immunosuppression. Tumor size at diagnosis can be used as a marker to select the most feasible type of treatment.
From the most popular Cancer Treatment Books, A Cancer Treatment Based on Synergy Between Anti-angiogenic and Immune Cell Therapies is the one of great book to have. You can get ebook from:
There are so many ebooks about A Cancer Treatment Based on Synergy Between Anti-angiogenic and Immune Cell Therapies that are available to have. Thinking of having A Cancer Treatment Based on Synergy Between Anti-angiogenic and Immune Cell Therapies ebook? You are in the right place. Get the ebook A Cancer Treatment Based on Synergy Between Anti-angiogenic and Immune Cell Therapies by: .
- Book was ranked at 3 by Google Books for A Cancer Treatment Based on Synergy Between Anti-angiogenic and Immune Cell Therapies
- A Cancer Treatment Based on Synergy Between Anti-angiogenic and Immune Cell Therapies published by since 2016 with ISBNs. The book ISBN 13 Code is and ISBN 10 Code is
- Reading Mode in Text Status is false and Reading Mode in Image Status is false
- The book has " Pages" is Printed at BOOK under Category
- Rated by Raters and have average rate at ""
- eBook Maturity (Adult Book) status is NOT_MATURE
- eBook written in en
- Book Preview Address: http://books.google.com/books?id=reTVvQEACAAJ&dq=Cancer+Treatment&hl=&cd=322&source=gbs_api
Book Preview
- Server 2: SECURE LINK